Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats
- PMID: 21196089
- PMCID: PMC3466100
- DOI: 10.1016/j.drugalcdep.2010.11.023
Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats
Abstract
Cocaine addiction is characterized by a persistently heightened susceptibility to drug relapse. For this reason, the identification of medications that prevent drug relapse is a critical goal of drug abuse research. Drug re-exposure, the onset of stressful life events, and exposure to cues previously associated with drug use have been identified as determinants of relapse in humans and have been found to reinstate extinguished cocaine seeking in rats. This study examined the effects of acute oral (gavage) administration of levo-tetrahydropalmatine (l-THP), a tetrahydroprotoberberine isoquinoline with a pharmacological profile that includes antagonism of D1, D2 and D3 dopamine receptors, on the reinstatement of extinguished cocaine seeking by a cocaine challenge (10mg/kg, ip), a stressor (uncontrollable electric footshock [EFS]) or response-contingent exposure to a stimulus (tone and light complex) previously associated with drug delivery in male Sprague-Dawley rats. Extinguished drug seeking was reinstated by ip cocaine, EFS, or response-contingent presentation of drug-associated cues in vehicle-pretreated rats following extinction of iv cocaine self-adminisration. Oral administration of either 3.0 or 10.0mg/kg l-THP 1h prior to reinstatement testing significantly attenuated reinstatement by each of the stimuli. Food-reinforced responding and baseline post-extinction responding were significantly attenuated at the 10.0, but not the 3.0mg/kg, l-THP dose, indicating that the effects of 3mg/kg l-THP on reinstatement were likely independent of non-specific motor impairment. These findings further suggest that l-THP may have utility for the treatment of cocaine addiction.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Figures





Similar articles
-
l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.Future Med Chem. 2012 Feb;4(2):177-86. doi: 10.4155/fmc.11.166. Future Med Chem. 2012. PMID: 22300097 Free PMC article. Review.
-
Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats.Psychopharmacology (Berl). 2007 Jul;192(4):581-91. doi: 10.1007/s00213-007-0754-7. Epub 2007 Mar 15. Psychopharmacology (Berl). 2007. PMID: 17361394
-
Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in rats.Pharmacol Biochem Behav. 2010 Dec;97(2):310-6. doi: 10.1016/j.pbb.2010.08.016. Epub 2010 Sep 9. Pharmacol Biochem Behav. 2010. PMID: 20816889 Free PMC article.
-
The dopamine receptor antagonist levo-tetrahydropalmatine attenuates heroin self-administration and heroin-induced reinstatement in rats.Pharmacol Biochem Behav. 2012 Jul;102(1):1-5. doi: 10.1016/j.pbb.2012.03.014. Epub 2012 Mar 27. Pharmacol Biochem Behav. 2012. PMID: 22741173
-
Levo-tetrahydropalmatine: A new potential medication for methamphetamine addiction and neurotoxicity.Exp Neurol. 2021 Oct;344:113809. doi: 10.1016/j.expneurol.2021.113809. Epub 2021 Jul 10. Exp Neurol. 2021. PMID: 34256045 Review.
Cited by
-
Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.Neuropsychopharmacology. 2016 Jan;41(1):335-56. doi: 10.1038/npp.2015.142. Epub 2015 May 15. Neuropsychopharmacology. 2016. PMID: 25976297 Free PMC article. Review.
-
l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.Future Med Chem. 2012 Feb;4(2):177-86. doi: 10.4155/fmc.11.166. Future Med Chem. 2012. PMID: 22300097 Free PMC article. Review.
-
Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands.Eur J Med Chem. 2017 Jan 5;125:255-268. doi: 10.1016/j.ejmech.2016.09.036. Epub 2016 Sep 14. Eur J Med Chem. 2017. PMID: 27688181 Free PMC article.
-
L-isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors.Drug Alcohol Depend. 2013 Dec 1;133(2):693-703. doi: 10.1016/j.drugalcdep.2013.08.021. Epub 2013 Sep 2. Drug Alcohol Depend. 2013. PMID: 24080315 Free PMC article.
-
Pharmacokinetics and Safety Assessment of l-Tetrahydropalmatine in Cocaine Users: A Randomized, Double-Blind, Placebo-Controlled Study.J Clin Pharmacol. 2017 Feb;57(2):151-160. doi: 10.1002/jcph.789. Epub 2016 Aug 4. J Clin Pharmacol. 2017. PMID: 27363313 Free PMC article. Clinical Trial.
References
-
- Ahmed SH, Koob GF. Cocaine- but not food-seeking behavior is reinstated by stress after extinction. Psychopharmacology. 1997;132:289–295. - PubMed
-
- Alleweireldt AT, Weber SM, Kirschner KF, Bullock BL, Neisewander JL. Blockade or stimulation of D1 dopamine receptors attenuates cue reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology. 2002;159:284–293. - PubMed
-
- Alleweireldt AT, Hobbs RJ, Taylor AR, Neisewander JL. Effects of SCH-23390 infused into the amygdala or adjacent cortex and basal ganglia on cocaine seeking and self-administration in rats. Neuropsychopharmacology. 2006;31:363–374. - PubMed
-
- Anderson SM, Schmidt HD, Pierce RC. Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking. Neuropsychopharmacology. 2006;31:1452–1461. - PubMed
-
- Anderson SM, Bari AA, Pierce RC. Administration of the D1-like dopamine receptor antagonist SCH-23390 into the medial nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug-seeking behavior in rats. Psychopharmacology. 2003;168:132–138. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources